Rich66
11-04-2008, 01:09 AM
Super cells fight cancer
<!-- START Dummy ad code - real code to be inserted instead. --> <!-- END Dummy ad code - real code to be inserted instead. -->
<!-- // .ad -->
<!-- // #section-header-ads -->
<!-- END Story Header Block --> <!-- START primary content/left column --> <!-- Story Toolbar-->
Font Size: Decrease (http://www.theaustralian.news.com.au/story/0,25197,24590917-23289,00.html#) Increase (http://www.theaustralian.news.com.au/story/0,25197,24590917-23289,00.html#)
Print Page: Print (javascript:print();)
<!-- // .article-tools --> <!-- End Story Toolbar--> November 03, 2008
<!-- // .module-subheader --> SCIENTISTS have created super-charged immune cells that helped beat back cancer tumours in half of a small group of patients tested.
Adding an artificial receptor to T-lymphocytes immune cells boosted their ability to fight a deadly form of cancer called neuroblastoma, according to a study released today.
Neuroblastoma attacks the nervous system. It accounts for 7 per cent of all childhood cancers, and 15 per cent of non-adult cancer deaths. In two-thirds of cases, it is not diagnosed until it has already spread to other parts of the body.
In their natural state, T-lymphocytes do not survive long and lack the molecules that would target cancer cells in tumours. To overcome this double deficiency, a team of researchers led by Malcolm Brenner at the Baylor College of Medicine in Houston, Texas, first selected immune cells naturally stimulated by a common but harmless virus called Epstein-Barr.
They then modified these cells to express a receptor keyed to specific proteins found in human neuroblastoma cells.
In tests on 11 neuroblastoma patients aged three to 10, tumours regressed in five cases and in a sixth the disease receded completely.
Professor Brenner and his team plan to add receptors for other cancers. The study was published online in the journal Nature Medicine.
AFP
<!-- START Dummy ad code - real code to be inserted instead. --> <!-- END Dummy ad code - real code to be inserted instead. -->
<!-- // .ad -->
<!-- // #section-header-ads -->
<!-- END Story Header Block --> <!-- START primary content/left column --> <!-- Story Toolbar-->
Font Size: Decrease (http://www.theaustralian.news.com.au/story/0,25197,24590917-23289,00.html#) Increase (http://www.theaustralian.news.com.au/story/0,25197,24590917-23289,00.html#)
Print Page: Print (javascript:print();)
<!-- // .article-tools --> <!-- End Story Toolbar--> November 03, 2008
<!-- // .module-subheader --> SCIENTISTS have created super-charged immune cells that helped beat back cancer tumours in half of a small group of patients tested.
Adding an artificial receptor to T-lymphocytes immune cells boosted their ability to fight a deadly form of cancer called neuroblastoma, according to a study released today.
Neuroblastoma attacks the nervous system. It accounts for 7 per cent of all childhood cancers, and 15 per cent of non-adult cancer deaths. In two-thirds of cases, it is not diagnosed until it has already spread to other parts of the body.
In their natural state, T-lymphocytes do not survive long and lack the molecules that would target cancer cells in tumours. To overcome this double deficiency, a team of researchers led by Malcolm Brenner at the Baylor College of Medicine in Houston, Texas, first selected immune cells naturally stimulated by a common but harmless virus called Epstein-Barr.
They then modified these cells to express a receptor keyed to specific proteins found in human neuroblastoma cells.
In tests on 11 neuroblastoma patients aged three to 10, tumours regressed in five cases and in a sixth the disease receded completely.
Professor Brenner and his team plan to add receptors for other cancers. The study was published online in the journal Nature Medicine.
AFP